Latest filing published 03 Sept 2026 for Abbott Laboratories, €37k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +5.6%Entry US$93.86 · Close 21 Oct 2026 US$99.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Philip P. Boudreau: trading record in brief
At Abbott Laboratories, Philip P. Boudreau appears as Vice President in 24 filings, dated from March 13, 2020 to September 1, 2026. The single purchase in the record, EUR 172,289 on April 23, 2026, makes up 20% of the open-market trades and sits among the 5 filings of the last twelve months.
The 4 sales total EUR 3,062,829, with a median of EUR 775,916. The three largest sit close together: EUR 871,465 on October 25, 2021, EUR 777,117 on March 13, 2020 and EUR 774,716 on June 16, 2023. The rest is mostly 18 grants.
Filings run from 1 to 5 a year, 2021 and 2026 being the busiest with 5 each. Filings are published a median of 3 days after the trade.
Boudreau has 2, 1 and 1 own market trades within 30 days of colleagues at Abbott Laboratories, in that order, every one in the same direction. Names in order: Andrea F. Wainer, Andrew H. Lane and Charles Brynelsen.
Companies and markets linked to Philip P. Boudreau
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 388 shares@ US$110.360.0000% mcap0.7% of flowCommon shares without par valueSEC:0001805099-26-000008:0
- 2,200 shares@ US$91.500.0001% mcap3.4% of flowCommon shares without par valueSEC:0001805099-26-000006:1Canonical exit: 22 Jul 2026 (T+90)
- 8,909 shares@ US$92.040.0005% mcap13.7% of flowCommon shares without par valueSEC:0001805099-26-000006:0
- 7,441 shares@ US$116.2614.3% of flowCommon shares without par valueSEC:0001805099-26-000004:0
- 27,997 shares0Common shares without par valueSEC:0001805099-26-000002:0
- 387 shares@ US$132.660.9% of flowCommon shares without par valueSEC:0001415889-25-023586:0
- 5,550 shares@ US$134.55112.5% of flowCommon shares without par valueSEC:0001415889-25-021451:0
- 4,908 shares@ US$135.8712.5% of flowCommon shares without par valueSEC:0001415889-25-006741:0
- 22,495 shares0Common shares without par valueSEC:0001415889-25-005885:0
- 387 shares@ US$113.270.8% of flowCommon shares without par valueSEC:0001415889-24-022823:0
- 1,738 shares@ US$120.053.8% of flowCommon shares without par valueSEC:0001415889-24-006402:0
- 23,024 shares0Common shares without par valueSEC:0001415889-24-005080:0
- 2,620 shares0Common shares without par valueSEC:0001415889-23-013036:0
- 8,000 shares@ US$106.0015.1% of flowCommon shares without par valueSEC:0001415889-23-010065:0
- 1,477 shares@ US$99.772.7% of flowCommon shares without par valueSEC:0001415889-23-003894:0
- 4,855 shares0Common shares without par valueSEC:0001415889-23-003046:0
- 1,192 shares@ US$122.412.6% of flowCommon shares without par valueSEC:0001415889-22-002186:0
- 966 shares@ US$116.791.6% of flowCommon shares without par valueSEC:0001415889-22-001730:1
- 5,351 shares0Common shares without par valueSEC:0001415889-22-001730:0
- 8,000 shares@ US$126.4917.0% of flowCommon shares without par valueSEC:0001415889-21-004996:0
- 704 shares@ US$121.581.1% of flowCommon shares without par valueSEC:0001415889-21-001197:0
- 937 shares@ US$123.041.5% of flowCommon shares without par valueSEC:0001415889-21-000885:1
- 4,997 shares0Common shares without par valueSEC:0001415889-21-000885:0
- 943 shares@ US$128.231.6% of flowCommon shares without par valueSEC:0001415889-21-000750:0
- 10,600 shares@ US$82.0013.2% of flowCommon shares without par valueSEC:0001179110-20-003729:0
25 of 25 declarations
